Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Bierman

Showing results (21-30 of 112) with videos related to

Pageof 12
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1996
Bone marrow transplantation in chronic lymphocytic leukemia and lymphomasZ S Pavletic, M R Bishop, P J Bierman, et al.
Seminars in Oncology|August 1, 1994
Salvage therapy for patients with lymphomaJ O Armitage, J M Vose, P J Bierman, et al.
In Vivo (Athens, Greece)|April 11, 2000
Partial review of immunotherapeutic pharmacology in stem cell transplantationP J Bierman, F Abe, S Buyukberber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
The role of high-dose therapy with hematopoietic stem cell rescue in low-grade non-Hodgkin's lymphomaM R Bishop, P J Bierman, J M Vose, et al.
Journal of Hematotherapy|January 1, 1993
Peripheral stem cell transplantation in non-Hodgkin's lymphoma patientsA Kessinger, J M Vose, P J Bierman, et al.
Cancer|February 1, 1992
Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignanciesJ M Vose, B C Kennedy, P J Bierman, et al.
Leukemia & Lymphoma|March 1, 1996
Central nervous system Hodgkin's disease relapsing with eosinophilic pleocytosisR J Hauke, S R Tarantolo, R M Bashir, et al.
Journal of Hematotherapy|February 1, 1995
Autologous bone marrow transplantation for Hodgkin's diseaseJ O Armitage, P J Bierman, J M Vose, et al.
Leukemia & Lymphoma|August 10, 1999
Limited stage I and II follicular non-Hodgkin's lymphoma: the Nebraska Lymphoma Study Group experienceH Tezcan, J M Vose, M Bast, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Phase I/II study incorporating intravenous hydroxyurea into high-dose chemotherapy for patients with primary refractory or relapsed and refractory intermediate-grade and high-grade malignant lymphomaW P Vaughan, E Kris, J Vose, et al.
Pageof 12

Showing results (21-30 of 112) with videos related to

Sort By:
Pageof 12
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1996
Bone marrow transplantation in chronic lymphocytic leukemia and lymphomasZ S Pavletic, M R Bishop, P J Bierman, et al.
Seminars in Oncology|August 1, 1994
Salvage therapy for patients with lymphomaJ O Armitage, J M Vose, P J Bierman, et al.
In Vivo (Athens, Greece)|April 11, 2000
Partial review of immunotherapeutic pharmacology in stem cell transplantationP J Bierman, F Abe, S Buyukberber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
The role of high-dose therapy with hematopoietic stem cell rescue in low-grade non-Hodgkin's lymphomaM R Bishop, P J Bierman, J M Vose, et al.
Journal of Hematotherapy|January 1, 1993
Peripheral stem cell transplantation in non-Hodgkin's lymphoma patientsA Kessinger, J M Vose, P J Bierman, et al.
Cancer|February 1, 1992
Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignanciesJ M Vose, B C Kennedy, P J Bierman, et al.
Leukemia & Lymphoma|March 1, 1996
Central nervous system Hodgkin's disease relapsing with eosinophilic pleocytosisR J Hauke, S R Tarantolo, R M Bashir, et al.
Journal of Hematotherapy|February 1, 1995
Autologous bone marrow transplantation for Hodgkin's diseaseJ O Armitage, P J Bierman, J M Vose, et al.
Leukemia & Lymphoma|August 10, 1999
Limited stage I and II follicular non-Hodgkin's lymphoma: the Nebraska Lymphoma Study Group experienceH Tezcan, J M Vose, M Bast, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Phase I/II study incorporating intravenous hydroxyurea into high-dose chemotherapy for patients with primary refractory or relapsed and refractory intermediate-grade and high-grade malignant lymphomaW P Vaughan, E Kris, J Vose, et al.
Pageof 12